ADBE
43
3
MDT
59
2
NWS
62
4
FLR
60
4
TXT
59
6
BXP
49
2
CI
40
2
VZ
37
3
GE
61
4
AIZ
54
7
TRV
48
2
CHD
45
3
K
56
5
WEC
45
4
VRTX
62
10
V
56
2
AMAT
46
6
JCI
45
4
WU
36
2
DG
27
-2
ADBE
43
3
MDT
59
2
NWS
62
4
FLR
60
4
TXT
59
6
BXP
49
2
CI
40
2
VZ
37
3
GE
61
4
AIZ
54
7
TRV
48
2
CHD
45
3
K
56
5
WEC
45
4
VRTX
62
10
V
56
2
AMAT
46
6
JCI
45
4
WU
36
2
DG
27
-2
Financhill
Back

Arcus Biosciences Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
46

RCUS
Arcus Biosciences

Last Price:
15.72
Seasonality Move:
10.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Arcus Biosciences Price Quote

$15.72
+0.43 (+2.81%)
(Updated: November 6, 2024 at 2:30 PM ET)

Arcus Biosciences Key Stats

Sell
46
Arcus Biosciences (RCUS) is a Sell
Day range:
$15.03 - $15.50
52-week range:
$12.95 - $20.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.06
P/B ratio:
2.2%
Volume:
530.9K
Avg. volume:
736.9K
1-year change:
-6.6%
Market cap:
$1.4B
Revenue:
$117M
EPS:
$-3.09

How Much Does Arcus Biosciences Make?

Is Arcus Biosciences Growing As A Company?

  • What Is Arcus Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Arcus Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arcus Biosciences Stock Price Performance

What Is Arcus Biosciences 52-Week High & Low?

Arcus Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arcus Biosciences?

  • How Much Debt Does Arcus Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arcus Biosciences Have?
    Cash and short term investments quarterly total is $969M
  • What Is Arcus Biosciences’s Book Value Per Share?
    Book value per share is 6.96

Is Arcus Biosciences Cash Flow Positive?

  • What Is RCUS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$247M
  • What Is Arcus Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $240M
  • What Is Arcus Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$67M

Arcus Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RCUS return on invested capital is -43.08%
  • What Is Arcus Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -20.8%
  • What Is RCUS Return On Equity?
    ROE is a measure of profitability and is -43.08%

Arcus Biosciences Earnings Date & Stock Price

Arcus Biosciences Competitors

  • Who Are Arcus Biosciences's Competitors?
    Below is a list of companies who compete with Arcus Biosciences or are related in some way:
    • Clearside Biomedical Inc (CLSD)
    • Intra-Cellular Therapies Inc (ITCI)
    • Janux Therapeutics Inc (JANX)
    • Merck & Co Inc (MRK)
    • Syndax Pharmaceuticals Inc (SNDX)

Arcus Biosciences Dividend Yield

Arcus Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 26.38%
Revenue: 34.48% 47.24%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 33.10
Upside from Last Price: 116.48%

Major Shareholders

  • How many RCUS shares are owned by institutional investors?
    83.7M RCUS shares are owned by institutional investors
  • How many RCUS shares are owned by insiders?
    5.1M RCUS shares are owned by insiders